ATE551100T1 - Pharmazeutische zusammensetzung zur behandlung von kardiovaskulären und cerebrovasakulären erkrankungen - Google Patents

Pharmazeutische zusammensetzung zur behandlung von kardiovaskulären und cerebrovasakulären erkrankungen

Info

Publication number
ATE551100T1
ATE551100T1 AT04762218T AT04762218T ATE551100T1 AT E551100 T1 ATE551100 T1 AT E551100T1 AT 04762218 T AT04762218 T AT 04762218T AT 04762218 T AT04762218 T AT 04762218T AT E551100 T1 ATE551100 T1 AT E551100T1
Authority
AT
Austria
Prior art keywords
cardiovascular
treatment
pharmaceutical composition
cerebrovascular diseases
cerebrovascular
Prior art date
Application number
AT04762218T
Other languages
English (en)
Inventor
Feng Wei
Dekun Li
Chongnian Luo
Hongshui Yue
Qingchuang Chen
Zhijuan Huang
Original Assignee
Tianjin Tasly Pharmaceutical
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tianjin Tasly Pharmaceutical filed Critical Tianjin Tasly Pharmaceutical
Application granted granted Critical
Publication of ATE551100T1 publication Critical patent/ATE551100T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A61K36/537—Salvia (sage)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
    • A61K36/258—Panax (ginseng)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
    • A61K36/254—Acanthopanax or Eleutherococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/481—Astragalus (milkvetch)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT04762218T 2003-09-23 2004-09-23 Pharmazeutische zusammensetzung zur behandlung von kardiovaskulären und cerebrovasakulären erkrankungen ATE551100T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CNB031443117A CN100339085C (zh) 2003-09-23 2003-09-23 治疗心脑血管疾病的中药组合物
PCT/CN2004/001085 WO2005051404A1 (fr) 2003-09-23 2004-09-23 Composition pharmaceutique pour le traitement de l'angiocardiopathie

Publications (1)

Publication Number Publication Date
ATE551100T1 true ATE551100T1 (de) 2012-04-15

Family

ID=34624426

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04762218T ATE551100T1 (de) 2003-09-23 2004-09-23 Pharmazeutische zusammensetzung zur behandlung von kardiovaskulären und cerebrovasakulären erkrankungen

Country Status (24)

Country Link
US (1) US7438935B2 (de)
EP (1) EP1679058B1 (de)
JP (1) JP4943846B2 (de)
KR (1) KR20070028283A (de)
CN (1) CN100339085C (de)
AP (1) AP1908A (de)
AT (1) ATE551100T1 (de)
AU (1) AU2004292351B2 (de)
BR (1) BRPI0414655B8 (de)
CA (1) CA2538478C (de)
DK (1) DK1679058T3 (de)
EA (1) EA009730B1 (de)
ES (1) ES2383599T3 (de)
LT (1) LT5433B (de)
MY (1) MY144043A (de)
NO (1) NO334431B1 (de)
NZ (1) NZ546654A (de)
PL (1) PL1679058T3 (de)
PT (1) PT1679058E (de)
SA (1) SA04250309B1 (de)
SI (1) SI1679058T1 (de)
UA (1) UA85065C2 (de)
WO (1) WO2005051404A1 (de)
ZA (1) ZA200603180B (de)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1895966A4 (de) * 2005-04-26 2010-01-20 Ko Boong Kyung Verfahren zur extraktion von ginsengnosid rg2m; pharmazeutische zusammensetzung mit ginsengnosid rg2, und ihre verwendungen
CN1305493C (zh) * 2005-06-09 2007-03-21 北京中医药大学 一种治疗脑中风的中药有效部位及其分离制备方法
KR101182917B1 (ko) * 2005-07-14 2012-09-13 내셔널 인스티튜트 오브 파마슈티컬 알앤디 컴퍼니 리미티드 인삼 2차 배당체를 함유하는 의약 조성물, 그의 제조 방법및 용도
CN1919253B (zh) * 2005-08-24 2010-12-01 天津天士力制药股份有限公司 一种治疗心脑血管疾病的药物组合物
CN1919237B (zh) * 2005-08-24 2011-10-05 天津天士力制药股份有限公司 治疗心脑血管疾病的药物
CN1919252B (zh) * 2005-08-24 2011-09-21 天津天士力制药股份有限公司 一种治疗心脑血管疾病的药物
CN1919238B (zh) * 2005-08-24 2011-10-05 天津天士力制药股份有限公司 一种治疗心脑血管病的药物
CN1919235B (zh) * 2005-08-24 2010-12-01 天津天士力制药股份有限公司 治疗心脑血管疾病的药物组合物
CN1919236B (zh) * 2005-08-24 2010-09-29 天津天士力制药股份有限公司 治疗心脑血管病的药物
CN100400047C (zh) * 2006-04-05 2008-07-09 黑龙江省珍宝岛制药有限公司 一种用于治疗心脑血管疾病的粉针剂及其制备方法和应用
CN100563662C (zh) * 2006-11-28 2009-12-02 中国科学院上海药物研究所 治疗心血管疾病的中药有效成分组合物及其制备方法
CN101322801B (zh) 2007-06-15 2011-07-20 河北以岭医药研究院有限公司 一种中药组合物在制备治疗扩张型心肌病药物中的应用
CN101439078B (zh) * 2007-11-22 2012-03-28 天津天士力制药股份有限公司 一种含黄芪提取物的中药颗粒及其制备方法
CN101439079B (zh) * 2007-11-22 2012-04-18 天津天士力制药股份有限公司 一种含黄芪总皂甙的中药颗粒的制备方法
CN101439076B (zh) * 2007-11-22 2012-04-18 天津天士力制药股份有限公司 一种含降香油的中药颗粒的制备方法
CN101524352A (zh) * 2008-03-04 2009-09-09 江苏先声药物研究有限公司 一种含有3-甲基-1-苯基-2-吡唑啉-5-酮的组合物
WO2010111935A1 (zh) * 2009-03-30 2010-10-07 天津天士力制药股份有限公司 一种新的丹酚酸化合物l、其制备方法和用途
CN102028748A (zh) * 2009-09-29 2011-04-27 天津天士力现代中药资源有限公司 一种治疗冠心病的药物及提取工艺
CN102028739B (zh) * 2009-09-29 2014-01-29 天津天士力现代中药资源有限公司 一种治疗冠心病的药物及其制备方法
KR101286870B1 (ko) * 2009-11-30 2013-07-16 (주)아모레퍼시픽 황기 추출물을 포함하는 대사 촉진 조성물
CN102160872A (zh) * 2010-02-23 2011-08-24 天津天士力制药股份有限公司 复方丹参滴丸胶囊
CN102293824A (zh) * 2010-06-28 2011-12-28 天津天士力制药股份有限公司 一种中药组合物在制备改善急性心肌梗死后的生活质量的药物中的应用
EP2601958B1 (de) 2010-08-06 2017-03-29 Tasly Pharmaceutical Group Co., Ltd. Verwendung einer salvia-miltiorrhiza-zusammensetzung bei der herstellung von arzneimitteln zur sekundären prävention der koronaren herzkrankheit
CN102670759A (zh) * 2012-05-18 2012-09-19 王显 治疗动脉粥样硬化的中药组合物
KR20140080289A (ko) 2012-12-20 2014-06-30 대전대학교 산학협력단 산화적 뇌손상 및 뇌기능 장애의 예방 또는 치료용 조성물 및 이의 제조방법
CN103070909B (zh) * 2013-01-04 2015-07-29 云南金七制药有限公司 三芪软胶囊及其制备方法
MX376094B (es) 2013-07-11 2025-03-07 Talsy Pharmaceutical Group Co Ltd Composición de medicina china tradicional, y preparación y aplicación de la misma.
WO2015003661A1 (zh) 2013-07-11 2015-01-15 天士力制药集团股份有限公司 一种中药微滴丸的制备方法以及由所述方法制得的中药微滴丸
ES3034682T3 (en) 2013-07-11 2025-08-21 Tasly Pharmaceutical Group Co Traditional chinese medicine composition, and preparation and application thereof
CN104418744B (zh) 2013-08-29 2017-03-01 天士力制药集团股份有限公司 一种新的丹酚酸化合物t、其制备方法和用途
CN104013831B (zh) * 2014-06-05 2017-06-23 黄艳梅 一种治疗脑供血不足的药物
CN106632572B (zh) * 2016-12-16 2018-08-14 中国科学院成都生物研究所 一种黄芪甲苷衍生物及其制备方法和应用
KR101892392B1 (ko) 2017-06-12 2018-08-27 오형근 고혈압 및 당뇨 개선을 위한 조성물
CN107582977A (zh) * 2017-10-18 2018-01-16 海南梵思科技有限公司 一种治疗心血管疾病的中药组合物及其制备方法
FR3076458B1 (fr) * 2018-01-05 2022-06-24 Soc Ind Limousine Dapplication Biologique Utilisation cosmetique d'extraits de racines de salvia miltiorrhiza, extraits particuliers de racines de salvia miltiorrhiza et compositions cosmetiques incluant de tels extraits
EP3542788A1 (de) 2018-03-19 2019-09-25 MC2 Therapeutics Limited Topische zusammensetzung enthaltend calcipotriol und betamethason dipropionat
TW201944990A (zh) * 2018-04-04 2019-12-01 大陸商天士力醫藥集團股份有限公司 預防和/或治療缺血再灌注損傷的中藥組合物及其製劑和應用
CN109394832A (zh) * 2018-10-29 2019-03-01 华玉海 一种治疗心脑血管病的复方滴丸及其制备方法
CA3167884A1 (en) * 2020-04-29 2021-11-04 He SUN Application of a traditional chinese medicine composition and formulation thereof in the preparation of medicaments for preventing and/or treating novel coronavirus pneumonia
CN113925892B (zh) * 2020-06-29 2024-04-09 天士力医药集团股份有限公司 中药芪参益气制剂治疗胃出血的用途
CN111991533A (zh) * 2020-09-11 2020-11-27 吉林省中医药科学院（吉林省中医药科学院第一临床医院） 一种治疗冠心病的中药组合物
JP2024537585A (ja) * 2021-09-27 2024-10-16 タスリー・ファーマシューティカル・グループ・カンパニー・リミテッド 心筋虚血の治療のための医薬組成物及びその製造方法

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0577943B1 (de) 1992-06-29 1996-06-26 Elpatronic Ag Verfahren zum Zuführen von Dosenzargen zu einer Dosenschweissstation sowie Vorrichtung zu dessen Durchführung
CN1025774C (zh) * 1992-11-14 1994-08-31 连汝安 一种特效型山海丹及其生产方法
CN1041494C (zh) * 1993-01-01 1999-01-06 河南省中药研究所 用于治疗慢性缺血性心脏病的一种中药散剂胶囊
CN1074613A (zh) * 1993-01-18 1993-07-28 邱天道 心泰膏
CN1085083C (zh) * 1993-02-17 2002-05-22 山海丹企业集团西安中医多学科研究所 治疗心绞痛型冠心病的药物及生产方法
CN1067244C (zh) * 1996-02-17 2001-06-20 昆明制药股份有限公司 三七皂甙粉针剂
CN1242364A (zh) 1998-07-22 2000-01-26 中国医科大学 治疗消化性溃疡的丹参提取物f及其制备工艺
CN1129572C (zh) 1998-09-11 2003-12-03 中国科学院上海药物研究所 丹参多酚酸盐混合物及其制备方法和用途
CN1095363C (zh) * 1999-05-05 2002-12-04 方同华 精制血塞通注射液的生产工艺
CN1274600A (zh) * 1999-05-24 2000-11-29 周金龙 一种治疗瘫痪的药物及其制备方法
CN1095674C (zh) * 1999-06-18 2002-12-11 贺云青 一种治疗脑血管病及风湿类风湿病的中草药组合物
CN1363288A (zh) * 2001-01-10 2002-08-14 杨孟君 纳米消栓再造制剂药物及其制备方法
CN1368061A (zh) * 2001-01-31 2002-09-11 杨孟君 纳米消栓通络制剂药物及其制备方法
CN1232267C (zh) * 2001-05-14 2005-12-21 成都中医药大学附属医院 用于治疗脑血管疾病的组合物及其制备方法和应用
US6589572B2 (en) * 2001-06-14 2003-07-08 Medvill Co., Ltd. Hypertension-treatment and cholesterol-depressant composition comprising extract from mixture of Panax notoginseng and Salvia miltiorrhiza and method of preparing the same
US6616943B2 (en) * 2001-08-31 2003-09-09 Fountain Silver Limited Composition comprising Wenguanguo extracts and methods for preparing same
CN1229324C (zh) * 2001-09-26 2005-11-30 中国医学科学院药物研究所 丹参总酚酸的提取方法及其制剂的制法与用途
TWI275396B (en) * 2001-10-17 2007-03-11 Braingenesis Biotechnology Co Composition of traditional Chinese medicines for preventing and treating cerebrovascular disease
CN1349818A (zh) * 2001-10-24 2002-05-22 沈阳药科大学 复方丹参有效部位群及其缓释制剂与医药用途和制备方法
CN1352985A (zh) 2001-11-27 2002-06-12 沈阳药科大学 中药丹参有效部位及其缓释制剂与医药用途和制备方法
CN1248702C (zh) * 2002-02-07 2006-04-05 天津天士力制药股份有限公司 治疗冠心病心绞痛的中药制剂及其制备方法
CN1202103C (zh) 2002-05-23 2005-05-18 天津天士力制药股份有限公司 丹参总酚酸的制备方法

Also Published As

Publication number Publication date
WO2005051404A1 (fr) 2005-06-09
UA85065C2 (ru) 2008-12-25
AP2006003596A0 (en) 2006-04-30
EA200600636A1 (ru) 2006-08-25
AU2004292351B2 (en) 2009-11-19
PT1679058E (pt) 2012-06-28
CN100339085C (zh) 2007-09-26
NO334431B1 (no) 2014-03-03
SA04250309B1 (ar) 2009-12-22
CA2538478A1 (en) 2005-06-09
NO20061764L (no) 2006-05-22
BRPI0414655A (pt) 2006-11-21
EP1679058A1 (de) 2006-07-12
CA2538478C (en) 2013-02-19
SI1679058T1 (sl) 2012-07-31
US20070053999A1 (en) 2007-03-08
WO2005051404A8 (en) 2006-04-27
EP1679058A4 (de) 2009-12-09
PL1679058T3 (pl) 2012-09-28
JP2007505936A (ja) 2007-03-15
CN1600319A (zh) 2005-03-30
MY144043A (en) 2011-07-29
EA009730B1 (ru) 2008-02-28
ZA200603180B (en) 2007-01-31
JP4943846B2 (ja) 2012-05-30
ES2383599T3 (es) 2012-06-22
US7438935B2 (en) 2008-10-21
EP1679058B1 (de) 2012-03-28
HK1089092A1 (en) 2006-11-24
BRPI0414655B8 (pt) 2021-05-25
NZ546654A (en) 2008-09-26
AP1908A (en) 2008-10-24
LT5433B (lt) 2007-07-25
KR20070028283A (ko) 2007-03-12
LT2006027A (lt) 2007-03-26
DK1679058T3 (da) 2012-06-25
AU2004292351A1 (en) 2005-06-09
BRPI0414655B1 (pt) 2017-03-07

Similar Documents

Publication Publication Date Title
EP1679058A4 (de) Pharmazeutische zusammensetzung zur behandlung von angiokardiopathie
DE60239648D1 (de) Pharmazeutische Zusammensetzungen zur Behandlung von Asthma
DE602004010407D1 (de) Fluorsubstituierter omega-carboxyaryldiphenylharnstoff zur behandlung und prävention von krankheiten und leiden
EP1851237A4 (de) Pharmazeutische zusammensetzungen zur behandlung oder prävention von knochenerkrankungen
DE602004028763D1 (de) Te zur behandlung von virenerkrankungen
DE602006018583D1 (de) Verfahren und zusammensetzung zur behandlung von peripheren gefässkrankheiten
DE50206657D1 (de) Pharmazeutische zusammensetzung zur behandlung von multiple sklerose
ATE381347T1 (de) Kombinationen von ezetimibe und aspirin zur behandlung von kardiovaskulären erkrankungen
DE602005020293D1 (de) Zur behandlung von hyperproliferationserkrankungen und mit angiogenese assoziierten krankheiten geeignete pyrrolotriazinderivate
ATE484494T1 (de) Substituierte indolderivate für eine pharmazeutische zusammensetzung zur behandlung von atemwegserkrankungen
DE602004022036D1 (de) Verfahren zur behandlung von atherosklerose, dyslipidämie und verwandten erkrankungen und pharmazeutische zusammensetzungen
ATE468331T1 (de) Neue cyanopyridine-derivate zur behandlung von krebs und anderer erkrankungen
ATE512163T1 (de) Verabreichung von mitteln zur behandlung von entzündungen
ATE443704T1 (de) Pyridopyrimidinone zur behandlung von krebserkrankungen
DE602004029465D1 (de) Externes Präparat zur Behandlung von Fusspilz
ATE446754T1 (de) Verbindungen zur behandlung von schizophrenie und/oder glucoregulatorische auffälligkeiten
DE60218375D1 (de) Pharmazeutische Zusammensetzung zur Behandlung gynäkologischer Erkrankungen
ATE482709T1 (de) Neue arzneimittelkombinationen zur behandlung von atemwegserkrankungen
DE602005016141D1 (de) S-mirtazapin zur behandlung von hitzewallungen
ATE517877T1 (de) Neue arzneimittel zur behandlung von atemwegserkrankungen
DE602004011275D1 (de) Zusammensetzungen und Verfahren zur Behandlung von Fettleibigkeit
DE60107900D1 (de) Pharmazeutische Zusammensetzung und Nahrungsmittel zur Behandlung von Gehirnödem
DE602004010172D1 (de) Pharmazeutische zusammensetzungen zur behandlung von nierenfunktionsstörungen
DE60215060D1 (de) Kräuterpräparat zur behandlung von herz-kreislauf- sowie neurologischen erkrankungen
DE602005015434D1 (de) Mittel zur behandlung von psychoneurotischen krankheiten